Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis. (Q39566627)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

C Damm-Welk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Pillon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Zimmermann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

G Franceschetto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

K Pulford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Reiter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Rosolen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

W Woessmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

18 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

416-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2012.205

11 February 2020

exact match

0 references

cites work

The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

[The 2008 WHO lymphoma classification]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference